News

Humira (adalimumab) proved effective in treating patients aged 5 and older with ulcerative colitis
Anne Griffiths, MD, of the Hospital for Sick Children in Toronto, spoke to the Advances in Inflammatory Bowel Diseases 2020 virtual meeting on research published this year into the special considerations involved in caring for children with Crohn disease and ulcerative colitis.
Do age, gender, development, and other characteristics in children with autism affect their likelihood of gastrointestinal symptoms? Researchers report their findings.
Data from previous studies suggest that gut microbiota play a critical part in the development of inflammatory bowel disease (IBD). In this study, researchers compared the intestinal microbiota of newly diagnosed pediatric patients with IBD with that of healthy siblings and healthy controls.
Endoscopic ultrasonography and endoscopic retrograde cholangiopancreatography are useful tools for the diagnosis and management of chronic pancreatitis in adults. The authors of the new NASPGHAN position paper determined whether the methods are also safe for pediatric patients.
The FDA has expanded the approval of a drug used for the treatment of C. difficile infection to include pediatric patients aged 6 months and older.
The authors of a new study presented at the NASPGHAN Annual Meeting and Postgraduate Course sought to determine the association between patient-, episode-, and emergency department care­–related variables and hospitalization among children with CVS.
The editors at Consultant360 have compiled a breakdown of top stories and recent pediatric gastroenterology news. See what you may have missed!
A new study examined the effect of a specific carbohydrate diet on fecal microbiome, and inflammatory bowel disease activity in children.
A new study examined the effect of a specific carbohydrate diet on fecal microbiome, and inflammatory bowel disease activity in children.